echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Organic Chemistry Topics > Organic Chemistry Products News > The Synthetic Routes of 4-[3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrile

    The Synthetic Routes of 4-[3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrile

    • Last Update: 2023-04-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The Synthetic Routes of 4-[3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrile: A Comprehensive Review


    4-[3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrile, commonly referred to as GDC-0980, is a potent and selective inhibitor of the protein kinase NEDD9, which is involved in the regulation of cell division and cancer progression.
    GDC-0980 has shown promising results in preclinical studies for the treatment of various cancers, making it an attractive target for further research and development.


    There are several synthetic routes to synthesize GDC-0980, each with its advantages and disadvantages.
    This article will provide a comprehensive review of the synthetic routes of GDC-0980, including their respective steps, reaction conditions, yields, and challenges.


    1. Synthetic Route 1: One of the most common synthetic routes to synthesize GDC-0980 involves the synthesis of the key intermediate, 4-chloro-2-methyl-2H-1,2,4-triazepine-3,5-dione.
      This intermediate can then be reacted with various substituted acetophenones to form the imidazolidine ring.

    Step 1: Synthesis of 4-chloro-2-methyl-2H-1,2,4-triazepine-3,5-dione


    To synthesize 4-chloro-2-methyl-2H-1,2,4-triazepine-3,5-dione, a common method involves the reaction of 2,3-dimethyl-4-nitro-5-phenyl-1,2,4-triazepine with hydrogen chloride in the presence of a Lewis acid catalyst, such as aluminum chloride.
    The reaction is followed by hydrolysis of the resulting nitro group with sodium hydroxide.


    Step 2: Synthesis of GDC-0980 via the Hagenberg reaction


    The imidazolidine ring of GDC-0980 can be synthesized using the Hagenberg reaction, which involves the reaction of the 2,3-dimethyl-4-nitro-5-phenyl-1,2,4-triazepine with 2,4-dinitro-5-chlorobenzene in the presence of a Lewis acid catalyst, such as aluminum chloride.
    The reaction is followed by hydrolysis of the resulting nitro group with sodium hydroxide, and then with a base, such as sodium hydroxide, to form the imidazolidine ring.


    1. Synthetic Route 2: Another synthetic route involves the synthesis of the key intermediate, 2-(4-chloro-3-(trifluoromethyl)phenylamino)-4,4-dimethyl-1,3-oxazolidine-3,4-dione.
      This intermediate can then be reacted with a variety of acetophenones to generate the imidazolidine ring.

    Step 1: Synthesis of 2-(4-chloro-3-(trifluoromethyl)phenylamino)-4,4-dimethyl-1,3-oxazolidine-3,4-dione


    To synthesize 2-(4-chloro-3-(trifluoromethyl)phenylamino)-4,4


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.